1 / 32

Diagnosis and Treatment of Obstructive Sleep Apnea in Adults

Diagnosis and Treatment of Obstructive Sleep Apnea in Adults. Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov. Outline of Material. Introduction to obstructive sleep apnea (OSA), diagnosis, and treatment. Systematic review methods.

mahola
Télécharger la présentation

Diagnosis and Treatment of Obstructive Sleep Apnea in Adults

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Diagnosis and Treatment of Obstructive Sleep Apnea in Adults Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov

  2. Outline of Material • Introduction to obstructive sleep apnea (OSA), diagnosis, and treatment. • Systematic review methods. • The clinical questions addressed by the comparative effectiveness review. • Results of studies and evidence based conclusions about the effectiveness and harms of OSA diagnosis and treatment. • Gaps in knowledge and future research needs. • What to discuss with patients and their caregivers. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  3. Background: Characteristics of Obstructive Sleep Apnea • Obstructive sleep apnea (OSA) involves repeated upper airway collapse during sleep. • This results in partial or complete cessation of breathing (hypopnea or apnea, respectively). • The frequency with which cessation of breathing occurs varies, but it can happen more than once each minute. • OSA symptoms include poor sleep quality, excessive sleeping, and daytime sleepiness. • Many people with OSA are asymptomatic. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. Victor LD. Am Fam Physician 1999;60:2279-86. PMID: 10593319.

  4. Background: Epidemiology of Obstructive Sleep Apnea • Obstructive sleep apnea (OSA) is relatively common in the United States. • It is most prevalent among the middle-aged and elderly, although it affects people of all ages. • The prevalence of OSA appears to be high and has been reported to be 10%–20% among middle-aged and older adults. • The prevalence of OSA among those aged 65 years and older is believed to be higher. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. Young T, Shahar E, Nieto FJ, et al. Arch Intern Med 2002;162:893-900. PMID: 11966340.

  5. Background: Adverse Clinical Outcomes Associated With Obstructive Sleep Apnea • Increased risk for cardiovascular disease. • Cardiac disease. • Hypertension. • Stroke. • Increased risk for noninsulin dependent diabetes and other metabolic abnormalities. • Increased likelihood of motor vehicle and other accidents due to daytime sleepiness. • Increased risk for perioperative and postoperative complications. • Decreased quality of life. • Decreased concentration. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. Victor LD. Am Fam Physician 1999;60:2279-86. PMID: 10593319; Punjabi NM. Proc Am Thorac Soc 2008;5:136-143. PMID: 18250205; Nieto FJ, Young TB, Lind BK, et al. JAMA 2000;283:1829-1836. PMID: 10770144; Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J, and the Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-51. PMID: 10080847; Young T, Palta M, Dempsey J, et al. N Engl J Med 1993;328:1230-5. PMID: 8464434.

  6. Background: Diagnosis of Obstructive Sleep Apnea (1 of 3) Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  7. Background: Diagnosis of Obstructive Sleep Apnea (2 of 3) • Polysomnography (PSG) is the current diagnostic standard for obstructive sleep apnea. • Portable sleep monitors can be used in a hospital, home setting, or sleep unit. • Questionnaires and clinical prediction rules are also used in diagnosis and for case finding. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. Polysomnography Task Force of the American Sleep Disorders Association Standards of Practice Committee. Sleep 1997;20:406-22. PMID: 9302725.

  8. Background: Diagnosis of Obstructive Sleep Apnea (3 of 3) • The apnea-hypopnea index (AHI) is used as a metric to diagnose obstructive sleep apnea (OSA) and to classify disease severity. • AHI = The number of apnea and hypopnea events per hour of sleep. • There is no current AHI threshold that indicates the need for treatment. • By consensus, individuals with few episodes of disordered breathing (often AHI <5 or <15 events per hour) are not formally diagnosed with OSA. • Individuals with frequent events (AHI ≥30 events/hr) are more likely to be at risk for adverse outcomes. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: diagnostic and coding manual. 2nd ed. 2005. Epstein LJ, Kristo D, Strollo PJ Jr. et al, for the Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2009;5:263-76. PMID: 19960649.

  9. Background: Treatment of Obstructive Sleep Apnea (1 of 2) • Continuous positive airway pressure machine • Oral devices, most commonly mandibular advancement device Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  10. Background: Treatment of Obstructive Sleep Apnea (2 of 2) • Surgery • Weight loss • Positional therapy • Oropharyngeal exercises • Nasal dilator strips • Atrial overdrive pacing • Acupuncture • Auricular plaster therapy • Drug therapies – ventilator stimulation, REM sleep suppression Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  11. Background: Challenges to Diagnosis and Treatment • The definition of obstructive sleep apnea (OSA) is inconsistent. • There is debate about the level of respiratory abnormality that defines the disorder. • There is also debate about the most appropriate approach to diagnose OSA. • Patient compliance is often a barrier to effective treatment. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. Trikalinos TA, Ip S, Raman G, et al. Home Diagnosis of Obstructive Sleep Apnea-Hypopnea Syndrome. August 2007. Available at: http://www.cms.gov/determinationprocess/downloads/id48TA.pdf. Parthasarathy S, Haynes PL, Budhiraja R, et al. J Clin Sleep Med 2006;2:133-42. PMID: 17557485.

  12. Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development • Topics are nominated through a public process, which includes submissions from health care professionals, professional organizations, the private sector, policymakers, members of the public, and others. •  A systematic review of all relevant clinical studies is conducted by independent researchers, funded by AHRQ, to synthesize the evidence in a report summarizing what is known and not known about the select clinical issue. The research questions and the results of the report are subject to expert input, peer review, and public comment. •  The results of these reviews are summarized into Clinician Guides and Consumer Guides for use in decisionmaking and in discussions with patients. The Guides and the full report, with references for included and excluded studies, are available at www.effectivehealthcare.ahrq.gov.

  13. Clinical Questions Addressed by the CER (1 of 2) • Key Question (KQ) 1: How do different available tests compare in their ability to diagnose OSA in adults with symptoms suggestive of disordered sleep? How do these tests compare in different subgroups of patients, based on: race, gender, body mass index (BMI), existing non-insulin dependent diabetes mellitus, existing cardiovascular disease, existing hypertension, clinical symptoms, previous stroke, or airway characteristics? • KQ2: How does phased testing (screening tests or battery followed by full test) compare to full testing alone? • KQ3: What is the effect of preoperative screening for OSA on surgical outcomes? Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  14. Clinical Questions Addressed by the CER (2 of 2) • Key Question (KQ) 4: In adults being screened for obstructive sleep apnea (OSA), what are the relationships between apnea-hypopnea index (AHI) or oxygen desaturation index, and other patient characteristics with long term clinical and functional outcomes? • KQ5: What is the comparative effect of different treatments for OSA in adults? • KQ6: In OSA patients prescribed nonsurgical treatments, what are the associations of pretreatment patient-level characteristics with treatment compliance? • KQ7: What is the effect of interventions to improve compliance with device use (positive airway pressure, oral appliances, positional therapy) on clinical and intermediate outcomes? Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  15. Rating the Strength of Evidence From the CER • The strength of evidence was classified into four broad categories: Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  16. Effectiveness of Portable Devices and Polysomnography • At-home monitors accurately predict elevated AHI suggestive of obstructive sleep apnea (OSA) (but cannot accurately estimate exact AHI values as measured by sleep-laboratory polysomnography): • Type II monitors. Strength of evidence: low • Type III and IV monitors. Strength of evidence: moderate • There is insufficient evidence to compare the different at-home monitors. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  17. Effectiveness of Questionnaires and Clinical Prediction Rules • The Berlin Questionnaire has high sensitivity and specificity in screening for obstructive sleep apnea (OSA). Strength of evidence: low • There is insufficient evidence to evaluate: • The commonly used STOP and STOP-Bang questionnaires. • The effectiveness of most questionnaires in screening for OSA. Strength of evidence: insufficient • Some clinical prediction rules (a morphometric model and a pulmonary function data model) may have predictive capacity, but these tools have not been validated externally. Strength of evidence: low Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  18. Effectiveness of Phased Testing and Preoperative Screening • There is insufficient evidence to evaluate the effectiveness of phased testing for detection of obstructive sleep apnea (OSA). Strength of evidence: insufficient • There is insufficient evidence to evaluate postoperative outcomes after mandatory preoperative screening for OSA. Strength of evidence: insufficient Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  19. Correlation of AHI with Health Outcomes • Severe obstructive sleep apnea (OSA) (AHI ≥30 events/hr) is a predictor of all-cause mortality (HR, 1.5–3.0). Strength of evidence: high • A high baseline AHI is correlated with diabetes (OR, 2.8–4.1). Strength of evidence: low • The strength of evidence is insufficient regarding the association between AHI and other clinical outcomes. Strength of evidence: insufficient AHI: apnea-hypopnea index; HR: hazard ratio; OR: odds ratio. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm. Botros N, Concato J, Mohsenin V, et al. Am J Med 2009;122:1122-7. PMID: 19958890. Reichmuth KJ, Austin D, Skatrud JB, et al. Am J Respir Crit Care Med 2005;172:1590-5. PMID: 16192452.

  20. Comparative Effectiveness of CPAP vs. MAD • CPAP and MAD improve sleepiness and lower AHI values when compared to control treatments or no treatment. Strength of evidence: moderate • CPAP is superior to MAD in achieving an AHI of ≤5 events per hour. Strength of evidence: moderate • Evidence is insufficient to address which patients might benefit most from treatment with CPAP, MAD, or CPAP compared to MAD. Strength of evidence: insufficient CPAP = continuous positive airway pressure machine; MAD = mandibular advancement device. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  21. Meta-analysis of Apnea-hypopnea Index in RCTs of MAD Versus CPAP Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  22. Comparative Effectiveness of Continuous Positive Airway Pressure Machines • Autotitrated continuous positive airway pressure machines (CPAP) and fixed CPAP are equally effective. Strength of evidence: moderate • Trials evaluating flexible CPAP (C-Flex) showed no statistically significant differences in compliance or other outcomes versus CPAP. Strength of evidence: low • Evidence is insufficient to compare other CPAP devices (oral CPAP, nasal CPAP, bilateral PAP, flexible bilateral PAP, and humidified CPAP or autoCPAP). Strength of evidence: insufficient • *Current research evaluates only intermediate outcomes, so these findings may not apply to long-term clinical outcomes. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  23. Effectiveness of Surgical Interventions • The studies for surgical interventions are limited, and current evidence is insufficient to determine their effectiveness when compared to sham, no treatment, or other obstructive sleep apnea (OSA) interventions. Strength of evidence: insufficient Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  24. Other Outcomes of Interest (1 of 2) • Weight-loss programs may be an effective treatment for OSA (vs. control interventions) in patients who are obese. Strength of evidence: low • There is insufficient evidence to compare the effectiveness of other treatments for OSA, such as drugs, implants, exercises, positional approaches, acupuncture, and nasal dilator strips. Strength of evidence: insufficient Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  25. Other Outcomes of Interest (2 of 2) • Compliance with OSA treatments: • High apnea-hypopnea index and Epworth sleepiness scale are predictors of improved CPAP compliance. Strength of evidence: moderate • Evidence is insufficient to evaluate potential predictors of mandibular advancement device compliance. Strength of evidence: insufficient • Some specific adjunct interventions may improve CPAP compliance, but studies are heterogeneous and no general type of intervention (e.g., education, telemonitoring) was more promising than others. Strength of evidence: low Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  26. Adverse Events: Continuous Positive Airway Pressure • Continuous positive airway pressure may be associated with the following adverse events: • claustrophobia, • nasal and oral dryness (including nosebleeds), • pressure discomfort, • gum or lip soreness or pain, • excessive salivation, • skin irritation, • nasal irritation and obstruction, • aerophagia, • abdominal distension, and • chest wall discomfort. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  27. Adverse Events: Mandibular Advancement Devices • Mandibular advancement devices may be associated with the following adverse events: • sleep disruption, • sensations of pressure in the mouth, • mucosal erosions, • excessive salivation, • dental crown damage, • loosening of teeth, and • tooth, mouth, and jaw pain/damage. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  28. Adverse Events: Surgery and Weight Loss • Surgery • Postsurgical complications • Infection, hemorrhage, nerve palsies, emergency surgical treatments, cardiovascular events, respiratory failure, rehospitalization, and death. • Long-term adverse events • Speech or voice changes, difficulty swallowing, and airway stenosis. • Weight-loss programs • No reported long-term adverse events. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  29. Conclusions (1 of 2) • A high apnea-hypopnea index (AHI) is associated with all-cause mortality and diabetes, so it is important to identify individuals with obstructive sleep apnea (OSA). • Portable monitors can predict a diagnosis of OSA, but additional studies are needed to prove their value compared with polysomnography. • Some questionnaires may be useful screening tools. • Continuous positive airway pressure remains the most effective treatment for OSA. • Mandibular advancement devices also improve sleepiness and reduce AHI. • In obese patients, weight-loss programs show promise as an effective treatment. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  30. Conclusions (2 of 2) • There is insufficient evidence to evaluate the effectiveness of other treatment options, including surgery. • Compliance remains a barrier to continuous positive airway pressure treatment, but there is insufficient evidence to evaluate compliance with other treatment options. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  31. Knowledge Gaps andFuture Research Needs • Current studies have not adequately evaluated long-term clinical outcomes. • There is insufficient clinical trial evidence to evaluate the effectiveness of many obstructive sleep apnea (OSA) treatments, including surgery. • No studies use subgroup analysis in evaluating the effectiveness of treatment. • Patient adherence is a major problem inhibiting the effectiveness of CPAP treatment, but the relative compliance rates with MAD or other treatment interventions have not been evaluated. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

  32. What To Discuss With Your Patientsand Their Caregivers • The serious negative health outcomes associated with obstructive sleep apnea (OSA). • Evidence is lacking for many long-term outcomes; however, intermediate outcomes such as sleepiness and the number of episodes of apnea and hypopnea can be improved. • The diagnostic and screening tools available to test for and evaluate OSA status and severity. • The potential benefits and adverse events associated with CPAP, MAD, and other treatment options – including the importance of compliance. • Patient preferences regarding diagnosis and treatment. Balk EM, Moorthy D, Obadan NO, et al. AHRQ Comparative Effectiveness Review No. 32. July 2011. Available at: http://www.effectivehealthcare.ahrq.gov/apnea.cfm.

More Related